Imperial College London

Professor Sir Roy Anderson FRS, FMedSci

Faculty of MedicineSchool of Public Health

Professor in Infectious Disease Epidemiology
 
 
 
//

Contact

 

roy.anderson Website

 
 
//

Assistant

 

Mrs Clare Mylchreest +44 (0)7766 331 301

 
//

Location

 

LG35Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Toor:2020:infdis/jiz609,
author = {Toor, J and Rollinson, D and Turner, HC and Gouvras, A and King, CH and Medley, GF and Hollingsworth, TD and Anderson, RM},
doi = {infdis/jiz609},
journal = {Journal of Infectious Diseases},
pages = {S525--S530},
title = {Achieving elimination as a public health problem for schistosoma mansoni and S. haematobium: when is community-wide treatment required?},
url = {http://dx.doi.org/10.1093/infdis/jiz609},
volume = {221},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - The World Health Organization (WHO) has set elimination as a public health problem (EPHP) as a goal for schistosomiasis. As the WHO treatment guidelines for schistosomiasis are currently under revision, we investigate whether school-based or community-wide treatment strategies are required for achieving the EPHP goal. In low- to moderate-transmission settings with good school enrolment, we find that school-based treatment is sufficient for achieving EPHP. However, community-wide treatment is projected to be necessary in certain high-transmission settings as well as settings with low school enrolment. Hence, the optimal treatment strategy depends on setting-specific factors such as the species present, prevalence prior to treatment, and the age profile of infection.
AU - Toor,J
AU - Rollinson,D
AU - Turner,HC
AU - Gouvras,A
AU - King,CH
AU - Medley,GF
AU - Hollingsworth,TD
AU - Anderson,RM
DO - infdis/jiz609
EP - 530
PY - 2020///
SN - 0022-1899
SP - 525
TI - Achieving elimination as a public health problem for schistosoma mansoni and S. haematobium: when is community-wide treatment required?
T2 - Journal of Infectious Diseases
UR - http://dx.doi.org/10.1093/infdis/jiz609
UR - https://www.ncbi.nlm.nih.gov/pubmed/31829414
UR - https://academic.oup.com/jid/article/221/Supplement_5/S525/5673803
UR - http://hdl.handle.net/10044/1/80182
VL - 221
ER -